已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Metaplastic breast carcinoma: a clinical-pathologic study of 97 cases with subset analysis of response to neoadjuvant chemotherapy

化生癌 医学 乳腺癌 肿瘤科 淋巴结 化疗 内科学 新辅助治疗 乳房切除术 癌症 病理 癌 乳腺癌
作者
Min Han,Arsalan Salamat,Li Zhu,Huina Zhang,Beth Z. Clark,David J. Dabbs,Gloria J Carter,Adam Brufsky,Rachel C. Jankowitz,Shannon L. Puhalla,Ronald R. Johnson,Atilla Soran,Jennifer G. Steiman,Priscilla F. McAuliffe,Emilia J. Diego,Rohit Bhargava
出处
期刊:Modern Pathology [Elsevier BV]
卷期号:32 (6): 807-816 被引量:90
标识
DOI:10.1038/s41379-019-0208-x
摘要

Metaplastic breast carcinoma is a rare heterogeneous category of breast cancer, often associated with a poor prognosis. Clinical-pathologic studies with respect to varied morphologic subtypes are lacking. There is also a dearth of studies assessing the response of metaplastic breast carcinoma to neoadjuvant chemotherapy. Cases of metaplastic breast carcinoma diagnosed between 2007 and 2017 were identified. Various clinical-pathologic variables were tested for association with survival. Patients who underwent neoadjuvant chemotherapy were assessed for pathologic response. Median age at diagnosis with metaplastic breast carcinoma was 64 years. With a median follow-up of 39 months, 26 patients (27%) recurred (24 distant and 2 loco-regional). The overall survival rate of the cohort was 66% (64/97). A number of variables were associated with survival in univariable analysis; however, in multivariable analysis, only lymph node status and tumor size (pT3 vs. pT1/2) were significantly associated with all survival endpoints: recurrence-free survival, distant recurrence-free survival, overall survival and breast cancer-specific survival. Twenty-nine of 97 (30%) patients with metaplastic breast carcinoma received neoadjuvant chemotherapy. Five (17%) patients achieved pathologic complete response. Matrix-producing morphology was associated with higher probability of achieving pathologic complete response (p = 0.027). Similar to other breast cancer subtypes, tumor size and lymph node status are prognostic in metaplastic carcinomas. The pathologic complete response rate of metaplastic breast carcinoma in our cohort was 17%, higher than previously reported. Although the matrix-producing subtype was associated with pathologic complete response, there was no survival difference with respect to tumor subtypes.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
唐唐发布了新的文献求助10
刚刚
标致从彤完成签到,获得积分10
刚刚
1秒前
Ray完成签到,获得积分10
4秒前
桐桐的应助被司新颖采纳,获得10
6秒前
诚心海云完成签到 ,获得积分10
7秒前
8秒前
8秒前
9秒前
我是老大的应助被科研通管家采纳,获得10
9秒前
传奇3的应助被科研通管家采纳,获得50
9秒前
888的应助被科研通管家采纳,获得30
9秒前
9秒前
Maestro_S的应助被科研通管家采纳,获得10
10秒前
10秒前
绿柏完成签到 ,获得积分10
10秒前
molihuakai的应助被科研通管家采纳,获得10
10秒前
11秒前
12秒前
张兔子完成签到 ,获得积分10
13秒前
严宇耕发布了新的文献求助10
13秒前
13秒前
alex的应助被我看看怎么个事采纳,获得10
13秒前
Lucas的应助被我看看怎么个事采纳,获得10
14秒前
ding的应助被我看看怎么个事采纳,获得10
14秒前
14秒前
14秒前
14秒前
14秒前
15秒前
15秒前
15秒前
15秒前
16秒前
唐唐发布了新的文献求助10
16秒前
JamesPei的应助被wu采纳,获得10
17秒前
雾眠气泡水完成签到 ,获得积分10
18秒前
机智的白卉的应助被perfectxl采纳,获得10
18秒前
正一笑完成签到,获得积分10
19秒前
司新颖完成签到,获得积分10
20秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8184723
求助须知:如何正确求助?哪些是违规求助? 9573702
关于积分的说明 21832740
捐赠科研通 7782090
什么是DOI,文献DOI怎么找? 3434404
关于科研通互助平台的介绍 2558528
邀请新用户注册赠送积分活动 2481054